Close Brothers upgraded to buy as broker calls Viceroy sell-off overdone

Shore Capital sets a 490p target for Close Brothers (down from 510p), implying a 42% upside, and upgrades the stock to 'buy' after shares fell sharply following a Viceroy Research report. Close Brothers' management rejects Viceroy's claims on motor finance commission liabilities, and Shore argues the short-seller's redress scenarios are materially exaggerated and that the current price more than compensates investors for residual regulatory uncertainty.

Analysis

The market reaction has likely compressed Close Brothers’ liquidity premium well beyond what fundamentals justify, driven by headline-driven flows and mechanical quant/CTA signals rather than new loss recognition. In a thin FTSE 250 market, headline uncertainty can amplify implied volatility by 2x–3x over days-to-weeks, creating a window where idiosyncratic, well-capitalised lenders can be purchased at stressed multiples.

Regulatory and remediation exposure is the key variable. Historical UK motor-finance redress programs have tended to result in concentrated, one-off provisions booked over 12–24 months rather than persistent margin erosion; only a systemic industry finding or class-wide litigation would force multi-year earnings destruction or a capital raise. That tail remains possible but low probability — the more likely paths are small-to-moderate provisions and protracted reputational noise.

A second-order industry shift is emerging: brokers and commission-led origination models will face accelerated contract redesign and margin reallocation, benefiting lenders with diversified origination channels, sticky deposit bases and direct-to-consumer capabilities. Over a 6–18 month horizon, expect pricing and underwriting tightening across motor finance originators, margin compression for pure-intermediary models, and potential M&A activity as weaker originators are re-priced.

Key short-term catalysts to watch are (1) FCA public commentary or thematic reviews, (2) company trading updates and provisioning cadence over the next two reporting windows, and (3) changes in short interest/put open interest which can force covering or further pressure. A non-event on any of these within 1–3 months should catalyse a material mean reversion trade; material adverse findings would push the timeframe out to 12–24 months and justify downside hedges.

Key Decisions for Investors

• Long CBG (Close Brothers) — tactically overweight 2–4% of portfolio; time horizon 3–6 months. Buy shares on continued headline weakness and immediately hedge tail risk with a short-dated (3 month) 15% OTM put to cap a drawdown; expected payoff is asymmetric if no regulatory bombshell materialises (low-cost hedge vs high upside from multiple re-rating).
• Collar strategy on CBG — buy shares and finance protection by selling a 3-month 25% OTM call (close-sized). This reduces net cost of downside protection and is appropriate if you expect limited upside in the near term but want to neutralise headline risk for a re-rating over 3–6 months.
• Pair trade — long CBG / short FTSE 250-financials ETF (or a short on a small-cap motor-finance name) sized beta-neutral; time horizon 1–3 months. This isolates idiosyncratic recovery potential while protecting against UK financial sector rotation; unwind if sector stress emerges (monitor systemic indicators and bank CDS widening).
• Tail hedge — buy 6–12 month CBG puts (deeper OTM) as insurance against a regulatory-outcome-driven capital hit; allocate small percentage of portfolio as disaster insurance given non-zero chance of a large remediation or litigatory outcome within 12–24 months.